Institutional Clinical and Translational Science Award
机构临床和转化科学奖
基本信息
- 批准号:10348879
- 负责人:
- 金额:$ 1016.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcademiaAddressAdherenceAdultAntihypertensive AgentsAreaBiological ModelsCell modelChildhoodCircadian DysregulationClinicalClinical ResearchClinical SciencesClinical and Translational Science AwardsCommunitiesComplexDevelopmentDisadvantagedDisciplineDiseaseDoseDrug ExposureEducational process of instructingFacultyFirst Independent Research Support and Transition AwardsFosteringFruitFunctional disorderFundingGenomic medicineGoalsGrowthHealth systemHomeHumanIncentivesIndustryInstitutesInstitutionIntensive CareIntervention TrialLeadershipLifeLipidsLondonMeasuresMessenger RNAMissionModelingPediatric HospitalsPennsylvaniaPharmaceutical PreparationsPharmacologic SubstancePhenotypePhiladelphiaPhysiologicalPhysiologyPilot ProjectsPricePrivate SectorRandomizedResearchResearch PersonnelResourcesRural CommunitySchoolsScienceSeriesSickle Cell AnemiaTestingThe Wistar InstituteTherapeuticTimeTranslatingTranslational ResearchUnited States National Institutes of HealthUniversitiesUrban CommunityValidationVisioncardiovascular risk factorclinical implementationclinical investigationcollegedrug actionimplementation barriersimplementation scienceimprovedimproved outcomemedical schoolsnovelnovel therapeuticsphenomicspre-clinicalprecision medicineprogramsrecruitresponsesuccesstranslational medicineuptake
项目摘要
Contact PD/PI: FITZGERALD, GARRET A
OVERALL
ABSTRACT/SUMMARY
The Institute for Translational Medicine and Therapeutics is the academic home for the CTSA in
Penn. For the past decade and a half the objectives of ITMAT have been and remain (i) to
increase the number of investigators capable of pursuing their research between proof of
concept in cells and model systems and (ii) elucidation of the mechanisms of human physiology,
disease or drug action through intense phenotyping in small numbers of people. The two
priorities of our CTSA are to foster the field of translational therapeutics and to bridge the
pediatric to adult divide across the entire spectrum of clinical and translational science. This
section describes how these priorities have influenced the growth of this CTSA Hub and outlines
our plans for the coming funding period.
Project Summary/Abstract Page 136
Contact PD/PI: FITZGERALD, GARRET A
OVERALL
NARRATIVE
The Institute for Translational Medicine and Therapeutics is the academic home for the CTSA in
Penn. For the past decade the specific aims of ITMAT have been and remain (i) to increase the
number of investigators capable of pursuing their research between proof of concept in cells
and model systems and (ii) elucidation of the mechanisms of human physiology, disease or
drug action through intense phenotyping in small numbers of people.
联系PD/PI:FITZGERALD,GARRET A
整体
摘要/总结
转化医学和治疗研究所是CTSA的学术之家,
宾夕法尼亚州在过去的15年里,ITMAT的目标一直是而且仍然是:
增加有能力在有证据证明
细胞和模型系统中的概念,以及(ii)阐明人体生理学的机制,
疾病或药物的作用,通过强烈的表型在少数人。两
我们的CTSA的优先事项是促进转化治疗领域,并弥合
从儿科到成人,跨越了临床和转化科学的整个范围。这
本节介绍了这些优先事项如何影响CTSA中心的发展,并概述了
我们对未来融资期的计划。
项目摘要/摘要第136页
联系PD/PI:FITZGERALD、GARRET A
整体
叙事
转化医学和治疗研究所是CTSA的学术之家,
宾夕法尼亚州在过去十年中,ITMAT的具体目标一直是而且仍然是:㈠增加
能够在细胞概念验证之间进行研究的研究人员人数
和模型系统,以及(ii)阐明人类生理学、疾病或
药物作用通过在少数人中的强烈表型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARRET A FITZGERALD其他文献
GARRET A FITZGERALD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARRET A FITZGERALD', 18)}}的其他基金
Institutional Clinical and Translational Sciences Award
机构临床和转化科学奖
- 批准号:
10487653 - 财政年份:2022
- 资助金额:
$ 1016.45万 - 项目类别:
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
动脉粥样硬化、前列腺素抑制和检查点封锁
- 批准号:
10304145 - 财政年份:2019
- 资助金额:
$ 1016.45万 - 项目类别:
Atherosclerosis, Prostaglandin Inhibition and Checkpoint Blockade
动脉粥样硬化、前列腺素抑制和检查点封锁
- 批准号:
10065018 - 财政年份:2019
- 资助金额:
$ 1016.45万 - 项目类别:
Institutional Clinical and Translational Science Award
机构临床和转化科学奖
- 批准号:
9261656 - 财政年份:2016
- 资助金额:
$ 1016.45万 - 项目类别:
Institutional Clinical and Translational Science Award
机构临床和转化科学奖
- 批准号:
10646280 - 财政年份:2016
- 资助金额:
$ 1016.45万 - 项目类别:
Institutional Clinical and Translational Science Award
机构临床和转化科学奖
- 批准号:
9562973 - 财政年份:2016
- 资助金额:
$ 1016.45万 - 项目类别:
Institutional Clinical and Translational Science Award
机构临床和转化科学奖
- 批准号:
10426378 - 财政年份:2016
- 资助金额:
$ 1016.45万 - 项目类别:
Institutional Clinical and Translational Science Award
机构临床和转化科学奖
- 批准号:
10227357 - 财政年份:2016
- 资助金额:
$ 1016.45万 - 项目类别:
Institutional Clinical and Translational Science Award
机构临床和转化科学奖
- 批准号:
10455191 - 财政年份:2016
- 资助金额:
$ 1016.45万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 1016.45万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 1016.45万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 1016.45万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 1016.45万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 1016.45万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 1016.45万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 1016.45万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 1016.45万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 1016.45万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 1016.45万 - 项目类别: